David Soper, M.D. – FDA Inspection, Feb 8, 2018

Record Details

This FDA Inspection record concerns David Soper, M.D., with an inspection on February 8, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: David Soper, M.D.
Inspection Date: February 8, 2018
Product Type: Drugs
Office: Center for Drug Evaluation and Research
Person: Ruth A. Williams (Company Rep)

View Company Profile

ID · 6f2adb40-b256-4a76-a809-a516e2f25c34

Inspection Facts

No Action Indicated (NAI)

No objectionable conditions or practices were found during the inspection.

Inspection number: 1042065
FDA center: Human Drugs
Project area: Bioresearch Monitoring

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore David Soper, M.D.

FDA Inspection

David Soper, M.D.February 8, 2018